Form 4: Casdin Partners Acquires Biolife Solutions Shares Following PanThera CryoSolutions Acquisition

Casdin Partners acquired 27,994 shares of Biolife Solutions Inc. common stock as part of the acquisition of PanThera CryoSolutions by Biolife Solutions.

Summary

• Casdin Partners Master Fund, L.P. acquired 27,994 shares of Biolife Solutions Inc. common stock on April 7, 2025.
• The acquisition was part of Biolife Solutions' purchase of PanThera CryoSolutions.
• Biolife Solutions acquired 90% of PanThera's common shares for $9.3 million in cash and 241,355 shares of Biolife Solutions' common stock.
• Following the transaction, Casdin Partners Master Fund, L.P. beneficially owns 8,735,159 shares of Biolife Solutions Inc.
• The reporting persons include Casdin Partners Master Fund, L.P., Casdin Capital, LLC, Casdin Partners GP, LLC, and Eli Casdin.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The acquisition itself is a positive development, and Casdin Partners maintaining a significant stake suggests confidence. However, there's no explicit forward-looking guidance to push the sentiment higher.

Positives

• The acquisition of PanThera CryoSolutions by Biolife Solutions could be a positive strategic move for Biolife Solutions.
• Casdin Partners' increased stake in Biolife Solutions may indicate confidence in the company's future prospects.

Risks

• The document does not explicitly mention any risks.
• However, acquisitions always carry integration risks and the potential for not achieving expected synergies.

Industry Context

The acquisition of PanThera CryoSolutions by Biolife Solutions suggests a move towards consolidating technologies or expanding product offerings within the biopreservation or cryopreservation industry.

Stakeholder Impact

• Shareholders of Biolife Solutions may see this acquisition as a positive step for the company's growth.
• Employees of PanThera CryoSolutions will likely be integrated into Biolife Solutions.
• Customers of both companies may benefit from a broader range of products and services.

Key Dates

Keywords

Biolife Solutions, Casdin Partners, PanThera CryoSolutions, acquisition, BLFS, common stock, beneficial ownership, SEC Form 4